CompareMarketResearchRequest a sample
Home / Healthcare / Drug Delivery Systems

Healthcare · Market report

Drug Delivery Systems Market Size, Share and Forecast 2026-2036

The global drug delivery systems market is worth USD 67.0 bn in 2026 and is forecast to reach USD 145 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Injectable devices is the largest by route segment.

USD 67.0 bnMarket size 2026
USD 145 bnForecast 2036
8.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global drug delivery systems market is worth USD 67.0 bn in 2026 and is forecast to reach USD 145 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Injectable devices is the largest by route segment.

ScopeDevices and technologies that deliver medicines into the body: inhalers, auto-injectors, pens, prefilled syringes, transdermal patches, infusion pumps and implantable drug depots.
IndustryHealthcare
Value 2025USD 62.0 bn
Value 2026USD 67.0 bn
Value 2036USD 145 bn
CAGR 2026-20368.0%
Volume 202632,239 million units
Volume 203666,215 million units
Average price 2026USD 2.08 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Drug Delivery Systems market size and forecast, 2026-2036

Exhibit 1The global drug delivery systems market is forecast to grow from USD 67.0 bn in 2026 to USD 145 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.0%
Drug Delivery Systems market value, 2025 to 2036Market value by year. 2025: USD 62.0 bn; 2026: USD 67.0 bn; 2027: USD 72.3 bn; 2028: USD 78.1 bn; 2029: USD 84.4 bn; 2030: USD 91.1 bn; 2031: USD 98.4 bn; 2032: USD 106 bn; 2033: USD 115 bn; 2034: USD 124 bn; 2035: USD 134 bn; 2036: USD 145 bn. Compound annual growth rate 2026 to 2036: 8.0%.202567.0 bn202698.4 bn2031145 bn20368.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 67.0 bn
2027USD 72.3 bn
2028USD 78.1 bn
2029USD 84.4 bn
2030USD 91.1 bn
2031USD 98.4 bn
2032USD 106 bn
2033USD 115 bn
2034USD 124 bn
2035USD 134 bn
2036USD 145 bn

Drug Delivery Systems market segmentation

By route

Exhibit 2Injectable devices is the largest segment by route, with 42.0% of 2026 revenueEstimated share of 2026 global revenue, by route
Drug Delivery Systems market share by route, 2026Share of 2026 revenue by route. Injectable devices: 42.0%; Inhalation: 25.0%; Oral controlled-release technologies: 14.0%; Transdermal and topical: 12.0%; Implantable and other: 7.0%.Injectable devices42.0%Inhalation25.0%Oral controlled-release technologies14.0%Transdermal and topical12.0%Implantable and other7.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Injectable devices42.0%50.5%USD 28.1 bn10.0%
Inhalation25.0%20.7%USD 16.7 bn6.0%
Transdermal and topical12.0%9.5%USD 8.0 bn5.5%
Oral controlled-release technologies14.0%11.6%USD 9.4 bn6.0%
Implantable and other7.0%7.7%USD 4.7 bn9.0%

By device type

Exhibit 3Prefilled syringes and pens adds the most revenue by device type, growing from USD 21.4 bn in 2026 to USD 53.8 bn by 2036Estimated revenue in USD by device type, 2026 and 2036 forecast
Drug Delivery Systems market by device type, 2026 and 2036Revenue by device type in 2026 and 2036. Prefilled syringes and pens: USD 21.4 bn in 2026, USD 53.8 bn in 2036, change +151%; Inhalers and nebulizers: USD 16.7 bn in 2026, USD 29.0 bn in 2036, change +73%; Auto-injectors and wearable injectors: USD 8.0 bn in 2026, USD 24.2 bn in 2036, change +201%; Patches and others: USD 11.4 bn in 2026, USD 19.7 bn in 2036, change +73%; Infusion pumps: USD 9.4 bn in 2026, USD 17.9 bn in 2036, change +90%.20262036 forecastChangePrefilled syringes and pens+151%21.4 bn53.8 bnInhalers and nebulizers+73%16.7 bn29.0 bnAuto-injectors and wearable injectors+201%8.0 bn24.2 bnPatches and others+73%11.4 bn19.7 bnInfusion pumps+90%9.4 bn17.9 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Prefilled syringes and pens32.0%37.2%USD 21.4 bn9.6%
Auto-injectors and wearable injectors12.0%16.7%USD 8.0 bn11.6%
Inhalers and nebulizers25.0%20.1%USD 16.7 bn5.7%
Infusion pumps14.0%12.3%USD 9.4 bn6.7%
Patches and others17.0%13.7%USD 11.4 bn5.7%

By therapy area

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Diabetes and metabolic25.0%26.0%USD 16.7 bn8.4%
Oncology19.0%19.0%USD 12.7 bn8.0%
Respiratory15.0%13.0%USD 10.0 bn6.5%
Pain and central nervous system15.0%15.0%USD 10.0 bn8.0%
Autoimmune and other26.0%27.0%USD 17.4 bn8.4%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals34.0%30.0%USD 22.8 bn6.7%
Home care30.0%37.0%USD 20.1 bn10.3%
Clinics and ambulatory centres22.0%21.0%USD 14.7 bn7.5%
Clinical trials and pharma14.0%12.0%USD 9.4 bn6.3%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Conventional delivery52.0%42.0%USD 34.8 bn5.7%
Controlled release28.0%28.0%USD 18.7 bn8.0%
Smart and connected devices12.0%20.0%USD 8.0 bn13.7%
Targeted and nano delivery8.0%10.0%USD 5.4 bn10.4%

Top 25 countries for drug delivery systems by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.5% of 2026 revenue and the 25 countries below together hold 94.5%.

Exhibit 4United States is the largest country market at USD 26.8 bn in 2026, and the three largest countries hold 55.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Drug Delivery Systems market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 26.8 bn, 40.0%; China: USD 5.4 bn, 8.0%; Germany: USD 4.7 bn, 7.0%; Japan: USD 4.0 bn, 6.0%; France: USD 2.7 bn, 4.0%; United Kingdom: USD 2.7 bn, 4.0%; Italy: USD 2.0 bn, 3.0%; India: USD 2.0 bn, 3.0%; Switzerland: USD 2.0 bn, 3.0%; Brazil: USD 1.7 bn, 2.5%.United States26.8 bn 40.0%China5.4 bn 8.0%Germany4.7 bn 7.0%Japan4.0 bn 6.0%France2.7 bn 4.0%United Kingdom2.7 bn 4.0%Italy2.0 bn 3.0%India2.0 bn 3.0%Switzerland2.0 bn 3.0%Brazil1.7 bn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 26.8 bn40.0%USD 55.9 bn7.6%
2ChinaUSD 5.4 bn8.0%USD 14.0 bn10.1%
3GermanyUSD 4.7 bn7.0%USD 9.8 bn7.7%
4JapanUSD 4.0 bn6.0%USD 7.2 bn6.0%
5FranceUSD 2.7 bn4.0%USD 5.3 bn7.2%
6United KingdomUSD 2.7 bn4.0%USD 5.6 bn7.7%
7ItalyUSD 2.0 bn3.0%USD 4.0 bn7.3%
8IndiaUSD 2.0 bn3.0%USD 5.8 bn11.2%
9SwitzerlandUSD 2.0 bn3.0%USD 4.3 bn8.0%
10BrazilUSD 1.7 bn2.5%USD 3.9 bn8.8%
11CanadaUSD 1.0 bn1.6%USD 2.2 bn7.8%
12South KoreaUSD 931 mn1.4%USD 2.0 bn7.8%
13SpainUSD 810 mn1.2%USD 1.7 bn7.8%
14AustraliaUSD 810 mn1.2%USD 1.7 bn7.8%
15NetherlandsUSD 696 mn1.0%USD 1.5 bn7.8%
16MexicoUSD 696 mn1.0%USD 1.9 bn10.3%
17IrelandUSD 583 mn0.9%USD 1.2 bn7.8%
18RussiaUSD 583 mn0.9%USD 1.2 bn7.8%
19TurkeyUSD 583 mn0.9%USD 1.5 bn10.3%
20BelgiumUSD 462 mn0.7%USD 983 mn7.8%
21DenmarkUSD 462 mn0.7%USD 983 mn7.8%
22Saudi ArabiaUSD 462 mn0.7%USD 1.2 bn10.3%
23SwedenUSD 462 mn0.7%USD 983 mn7.8%
24TaiwanUSD 462 mn0.7%USD 983 mn7.8%
25SingaporeUSD 348 mn0.5%USD 737 mn7.8%
Rest of worldUSD 3.7 bn5.5%USD 7.6 bn7.6%
Exhibit 5United States and China account for 49% of the USD 77.6 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Drug Delivery Systems market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 67.0 bn. United States: +USD 29.2 bn; China: +USD 8.7 bn; Germany: +USD 5.1 bn; India: +USD 3.8 bn; Japan: +USD 3.2 bn; 20 other countries: +USD 23.7 bn; Rest of world: +USD 4.0 bn. Market value 2036: USD 145 bn.Market value 202667.0 bnUnited States+29.2 bnChina+8.7 bnGermany+5.1 bnIndia+3.8 bnJapan+3.2 bn20 other countries+23.7 bnRest of world+4.0 bnMarket value 2036145 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Becton Dickinson
  • West Pharmaceutical Services
  • Gerresheimer
  • Ypsomed
  • SHL Medical
  • Owen Mumford
  • SCHOTT Pharma
  • Terumo

Group 2: Regional and specialist players

  • Baxter
  • Insulet
  • Phillips-Medisize
  • Nemera
  • Aptar Pharma
  • Stevanato Group
  • Nipro
  • Bespak
  • medmix
  • Catalent

Group 3: Emerging and niche players

  • Haselmeier
  • Credence MedSystems
  • Enable Injections
  • PharmaJet
  • Subcuject

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the drug delivery systems market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.

The market is divided by route, by device type, by therapy area, by end user, by technology. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the drug delivery systems market?

The global drug delivery systems market is estimated at USD 62.0 bn in 2025 and USD 67.0 bn in 2026.

How fast will the drug delivery systems market grow?

It is forecast to reach USD 145 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 77.6 bn.

Which country is the largest market for drug delivery systems?

United States is the largest market by revenue at USD 26.8 bn in 2026, 40.0% of the global total. The three largest countries together hold 55.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 11.2% a year from 2026 to 2036.

Which drug delivery systems segment is largest?

In the by route split, Injectable devices is the largest segment with 42.0% of 2026 revenue.

Who are the leading drug delivery systems companies?

Global leaders include Becton Dickinson, West Pharmaceutical Services, Gerresheimer, Ypsomed.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Downstream Processing Drug Discovery Services →

All Healthcare markets →

Request a sample